rdf:type |
|
lifeskim:mentions |
umls-concept:C0008976,
umls-concept:C0013175,
umls-concept:C0205210,
umls-concept:C0392756,
umls-concept:C0418981,
umls-concept:C0475224,
umls-concept:C0521447,
umls-concept:C0522523,
umls-concept:C0580822,
umls-concept:C0581603,
umls-concept:C1274040,
umls-concept:C1522318,
umls-concept:C1547300,
umls-concept:C1548760,
umls-concept:C1550594,
umls-concept:C1948041,
umls-concept:C2698651,
umls-concept:C2828008
|
pubmed:issue |
10
|
pubmed:dateCreated |
2008-3-11
|
pubmed:databankReference |
|
pubmed:abstractText |
Extent and severity of myocardial ischemia are determinants of risk for patients with coronary artery disease, and ischemia reduction is an important therapeutic goal. The Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) nuclear substudy compared the effectiveness of percutaneous coronary intervention (PCI) for ischemia reduction added to optimal medical therapy (OMT) with the use of myocardial perfusion single photon emission computed tomography (MPS).
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1524-4539
|
pubmed:author |
pubmed-author:BatesEric RER,
pubmed-author:BergerPeterP,
pubmed-author:BermanDaniel SDS,
pubmed-author:BodenWilliam EWE,
pubmed-author:COURAGE Investigators,
pubmed-author:ChaitmanBernard RBR,
pubmed-author:DadaMarcinM,
pubmed-author:FriedmanJohnJ,
pubmed-author:GermanoGuidoG,
pubmed-author:GosselinGilbertG,
pubmed-author:HartiganPamela MPM,
pubmed-author:HayesSean WSW,
pubmed-author:HellerGary VGV,
pubmed-author:KnudtsonMerillM,
pubmed-author:KostukWilliam JWJ,
pubmed-author:ManciniG B JohnGB,
pubmed-author:MaronDavid JDJ,
pubmed-author:McCallisterBenjaminB,
pubmed-author:O'RourkeRobert ARA,
pubmed-author:SchwartzRonald GRG,
pubmed-author:ShawLeslee JLJ,
pubmed-author:SlomkaPiotrP,
pubmed-author:SpertusJohn AJA,
pubmed-author:TeoKoon KKK,
pubmed-author:VeledarEmirE,
pubmed-author:WeintraubWilliam SWS
|
pubmed:issnType |
Electronic
|
pubmed:day |
11
|
pubmed:volume |
117
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1283-91
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:18268144-Aged,
pubmed-meshheading:18268144-Angioplasty, Balloon, Coronary,
pubmed-meshheading:18268144-Combined Modality Therapy,
pubmed-meshheading:18268144-Coronary Angiography,
pubmed-meshheading:18268144-Exercise Test,
pubmed-meshheading:18268144-Female,
pubmed-meshheading:18268144-Humans,
pubmed-meshheading:18268144-Kaplan-Meier Estimate,
pubmed-meshheading:18268144-Male,
pubmed-meshheading:18268144-Middle Aged,
pubmed-meshheading:18268144-Myocardial Ischemia,
pubmed-meshheading:18268144-Myocardial Revascularization,
pubmed-meshheading:18268144-Proportional Hazards Models,
pubmed-meshheading:18268144-Single-Blind Method,
pubmed-meshheading:18268144-Tomography, Emission-Computed, Single-Photon,
pubmed-meshheading:18268144-Treatment Outcome
|
pubmed:year |
2008
|
pubmed:articleTitle |
Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy.
|
pubmed:affiliation |
Emory University School of Medicine, Atlanta, GA 30306, USA. leslee.shaw@emory.edu
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, U.S. Gov't, Non-P.H.S.,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|